Categories: News

Whitney Medical Solutions Introduces the Pipet Keeper XL™ Disposing up to 75% More Biohazardous Objects in Laboratories Than the Standard Pipet Keeper™.

NILES, Ill., Jan. 26, 2022 /PRNewswire-PRWeb/ — Whitney Medical Solutions, Inc. is proud to announce the introduction of Pipet Keeper™ XL, the company’s newest product for disposing of biohazardous laboratory waste. The large new waste container allows laboratories to dispose of up to 75% more pipets, swabs, and other biohazardous objects than previously available with the standard Pipet Keeper™. With the Pipet Keeper™ XL, objects up to 16 inches in length are easily disposed of right at the workstation, an inch longer than the standard Pipet Keeper™. Biohazard waste can present a sizable risk in the lab. The Pipet Keeper ™ XL helps reduce the risk to lab staff and the environment.

Constructed from strong paperboard, a renewable resource, the Pipet Keeper™ XL is a cheaper solution than plastic containers, allowing laboratories safe biohazard disposal options at a low cost. Plastic lining with webbed corners gives Pipet Keeper XL™ the ability to hold moderate amounts of liquid and avoid soaking through, keeping workstations clean to meet high lab standards.

Simplify your waste disposal and recordkeeping requirements. The OSHA Bloodborne Pathogens Standard states for reusable containers: All bins, pails, cans, and similar receptacles intended for reuse which have a reasonable likelihood for becoming contaminated with blood or other potentially infectious material shall be inspected and decontaminated on a documented, regularly scheduled basis and cleaned and decontaminated immediately or as soon as feasible upon visible contamination [1910.1030(d)(4)(ii)(C)]. Disposable waste containers eliminate the need for recordkeeping and scheduled cleaning. The Pipet Keeper™ XL is a disposable container designed to be convenient and save time.

“Convenient and easy to assemble” – Angio BioCore
“Reduces biohazardous waste and less mess” – OHSU
“Fills an important need” – Georgia Tech

If you are interested in learning more about Pipet Keeper XL waste containers or would like to receive a sample, please visit http://www.PipetKeeperXL.com.

About Whitney Medical Solutions:
Whitney Medical Solutions™ is a designer and manufacturer of hospital supplies and medical devices. Founded in 1984, Whitney has served the medical community by developing innovative products for nearly 40 years. Focused on the medical community and the needs and issues that prevent medical professionals from getting their jobs done efficiently and effectively, Whitney finds Real Solutions For Real Problems™ in healthcare environments. Contact Whitney Medical Solutions at tel:800-338-4237 or visit their website at Whitney Medical Solutions.

Media Contact

Richa Patel, Whitney Medical Solutions, 1 8474709300 Ext: 111, rpatel@whitneyms.com

 

SOURCE Whitney Medical Solutions

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

4 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

7 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

7 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

7 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

7 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

7 hours ago